Corneal immunoimaging and neuroimaging approaches facilitate in vivo analyses of the cornea, including high-resolution imaging of corneal immune cells and nerves. This approach facilitates the analyses of underlying immune and nerve alterations not detected by clinical slit-lamp examination alone. In this review, we describe recent work performed in our translational ocular immunology center with a focus on "bench-to-bedside" and "bedside-to-bench" research. The ability to visualize dendritiform immune cells (DCs) in patients with laser in vivo confocal microscopy (IVCM), recently discovered in the central murine cornea, has allowed us to demonstrate their utility as a potential surrogate biomarker for inflammatory ocular surface diseases. This biomarker for inflammation allows the measurement of therapeutic efficacy of anti-inflammatory drugs and its utility as an endpoint in clinical trials with high interobserver agreement. IVCM image analyses from our studies has demonstrated a significant increase in DC density and size in ocular disease, a positive correlation between DC density and clinical signs and symptoms of disease and pro-inflammatory tear cytokines, and a strong negative correlation between DC density and subbasal nerve density. In conjunction with preclinical research investigating the inflammatory state in a partial or fully denervated cornea, our results indicated that corneal nerves are directly involved in the regulation of homeostasis and immune privilege in the cornea.
T he cornea is the window to the foreign world and it is an immune-privileged tissue. Corneal immune privilege is dependent, in part, on the absence or low expression of major histocompatibility complex (MHC) class I and II antigens, lack of blood vessels that limit access of the immune system to the cornea, lack of lymphatic vessels that prevent the egress and delivery of antigens and antigen-presenting cells (APCs) to T cells in the draining lymph nodes (dLNs), the presence of anti-inflammatory molecules such as transforming growth factor-b, and the presence of Fas ligand, resulting in the apoptosis of infiltrating T cells. [1] [2] [3] Historically, the cornea, with the exception of a population of intraepithelial MHC-II + dendritic cells in the peripheral/limbal region, was believed to be a tissue devoid of bone marrow-derived cells. 2, 4 This dogma was challenged at the turn of the century, after the identification of resident corneal APCs distributed throughout the central cornea during steady state. [5] [6] [7] [8] [9] [10] 
CORNEAL DENDRITIC CELLS IN CORNEAL IMMUNITY
Professional APCs in the naive cornea include CD45 + CD11c + epithelial and stromal conventional dendritic cells (cDCs). During homeostasis, corneal cDCs are immature in the central cornea (MHC-II-, CD80-, and/or CD86negative) and both immature and mature (MHC class II-, CD80-, and/or CD86-positive) in the peripheral cornea. In contrast, the density and maturation of cDCs increase throughout the cornea during inflammation. [5] [6] [7] [8] [9] The important role of inflammation, corneal APCs, and cDCs in the pathogenesis of ocular surface diseases, including dry eye disease (DED), has been firmly established. It has been demonstrated that desiccation results in an inflammatory microenvironment and maturation of cDCs during the induction of DED, facilitating their migration to dLNs, subsequently activating T cells toward T helper (Th)1 and Th17 (autoreactive) subtypes. [11] [12] [13] [14] [15] [16] Similarly, an inflammatory response to noxious pathogens leads to inflammation, nerve damage, and other complications associated with infectious keratitis. 17 Examples of clinically relevant ocular infections include herpes simplex virus (HSV) type 1, as well as Acanthamoeba and Pseudomonas aeruginosa. However, the use of clinical slit-lamp biomicroscopy alone cannot detect the underlying immune and nervous changes during the various severity grades of DED and infectious keratitis.
CLINICAL IMMUNOIMAGING WITH IN VIVO CONFOCAL MICROSCOPY
The recent advent of laser in vivo confocal microscopy (IVCM), a noninvasive high-resolution real-time imaging device, allows layer-by-layer analysis of the corneal ultrastructure in both ocular health and disease, with images comparable to those produced using ex vivo histochemical techniques. [18] [19] [20] Of the 2 corneal confocal microscopes currently in clinical use, the Heidelberg Retinal Tomograph 3 with the Rostock Corneal Module (HRT3/RCM; Heidelberg Engineering GmBH, Heidelberg, Germany) laser IVCM allows for visualization and differentiation of hyperreflective dendritiform immune cells (DCs) 21 and improved visualization of subbasal nerves 22 as compared with the Confoscan 4 (NIDEK Co, Ltd, Aichi, Japan) ( Fig. 1 ). 18, 19, [23] [24] [25] [26] Thus, with the availability of laser IVCM, alterations of the corneal immune system can now be assessed and quantified in the clinic, allowing for the assessment of inflammation, tailored therapeutic decision making, and the monitoring of disease progression and responses to therapy in corneal diseases, such as DED and infectious keratitis. 20 In addition, although the cornea is the most densely innervated tissue of the body, in vivo assessments in patients have remained problematic. However, laser IVCM now facilitates in vivo assessment and quantification of corneal nerves (Fig. 2 ). 18 Our initial findings in a prospective controlled study analyzing IVCM images from patients with bacterial, fungal, and Acanthamoeba keratitis revealed a significantly higher epithelial DC density compared with normal control subjects. 22 Interestingly, this increase in DC density was inversely correlated with corneal nerve density in these patients. More recent comparisons of standard 400 · 400-mm single images with wide-field composite images revealed no significant differences in the mean subbasal nerve and DC densities between the average values of 3 representative standard IVCM images and wide-field mapped composite images. 27 Therefore, standard IVCM images in clinical studies are appropriate for the accurate measurements of cellular changes in the subbasal layer with a high interobserver agreement in quantification (R = 0.997, P , 0.001). 27 To determine whether cellular DC changes are a sign of inflammation, we compared changes in DC density with pro-inflammatory tear cytokines in patients with bacterial keratitis. Alterations in DC density in patients with unilateral bacterial keratitis correlated positively with a bilateral increase in pro-inflammatory tear cytokines, including interleukin (IL)-1b and IL-6, in addition to ipsilateral changes in IL-8 and IL-17a. 28 To assess the degree of immune activation and inflammation in patients with DED, we initially investigated differential changes in DC density and morphological parameters in patients with subtypes of DED. 29 Our results demonstrated that DC density, but not DC morphology, was significantly higher in the aqueous-deficient subtype compared with the evaporative subtype. Furthermore, aqueousdeficient DED with underlying systemic immune diseases had significantly higher DC density and morphological alterations compared with non-immunologic diseases, which suggests that DC changes reflect the degree of immune activation and inflammation and may thus be used for clinical practice and clinical trials. 29 The subsequent assessment of clinical DC density by IVCM in a recent phase IV randomized trial in patients with evaporative DED demonstrated a significant correlation between corneal DC density and clinical signs of corneal fluorescein staining and symptoms as measured by the ocular surface disease index, highlighting the utility of DC density as a potential surrogate biomarker for ocular surface inflammation. 30 This clinical trial also demonstrated that alterations in DC density and morphology as endpoint measurements by IVCM could be used successfully to determine the antiinflammatory therapeutic efficacy of topical loteprednol compared with artificial tears. 31 Thus, in addition to its utility as an endpoint in clinical trials, image-guided evaluation allows for personalized treatment based on cellular alterations specific to each patient. How resident immune cells are regulated in the homeostatic cornea, and how this regulation is lost in keratitis, remains an area of investigation.
CLINICAL NEUROIMAGING WITH IN VIVO CONFOCAL MICROSCOPY
Corneal nerve dysfunction is the pathophysiological basis of many ocular surface diseases arising from DED, 26, 32 surgery, 33 diabetic neuropathy, [34] [35] [36] [37] contact lens wear, corneal neuralgia, 38 corneal neuropathy-induced photoallodynia, 39 and small fiber neuropathy. 40 Of particular interest has been the correlation of subbasal corneal nerves to their function, given their pivotal role in the regulation of corneal sensation, maintenance of epithelial integrity, and proliferation and the promotion of wound healing. Our analyses of corneal IVCM images in patients with infectious keratitis revealed a significant decrease in nerve density, number of nerve branches, number of main nerve trunks, and total number of nerves in patients with keratitis infected with bacteria, fungi, and Acanthamoeba. 22 Moreover, we recently reported that although the corneal subbasal nerve plexus regenerates during the first 6 months after the resolution of infectious keratitis and cessation of therapy, it does not fully recover to baseline levels. 41 Notably, the decrease in nerve density in patients with infectious keratitis resulted in an inverse correlation with DC density. 22 Furthermore, in separate studies, we reported that the contralateral unaffected eyes of patients with unilateral infectious keratitis, including herpes simplex, herpes zoster, Acanthamoeba, fungal, and bacterial keratitis, showed a bilateral decrease in the subbasal nerve plexus, compared with controls. 19, 42, 43 Finally, DC density in the contralateral unaffected eyes was significantly increased compared with controls, albeit not as dramatically as in affected eyes with acute infectious keratitis. Thus, the strong correlation between the clinical density of subbasal nerves and DCs suggests a potential direct interaction between the immune and nervous systems in the cornea.
EXPERIMENTAL EVIDENCE OF CORNEAL NEUROIMMUNE CROSSTALK
The neural control of ocular immune privilege was initially proposed by Streilein et al. 44 Neuropeptides, such as a-melanocyte-stimulating hormone and vasoactive intestinal peptide, are typically released from nerve termini. In addition to their role as neurotransmitters, these peptides are immunomodulatory and are present in the cornea. 44 Neuropeptides suppress pro-inflammatory cytokine production by leukocytes and other resident cells, [44] [45] [46] [47] [48] and participate in maintaining inflammation at a minimum in the cornea. 44 Corneal nerve damage is common clinically and may occur after surgical procedures, infectious keratitis, diabetes, and inflammatory diseases, such as DED, resulting in complete or partial neurotrophic keratopathy (NTK). However, the exact relationship between the immune and nervous systems in the cornea in relation to adaptive immunity of corneal transplantation remains poorly understood.
Our previous clinical data indicated that corneal nerves may be directly involved in the regulation of the immune system and immune privilege in the cornea. Although the role of peripheral nerves in the regulation of neuropeptides and innate immunity has been demonstrated in other peripheral sites, [44] [45] [46] [47] [48] the regulation of the adaptive immune system and the maintenance of immune privilege by peripheral nerves have not been reported. Thus, we next developed several animal models to investigate the potential immunomodulatory roles of corneal nerves.
We initially developed a corneal denervation model using a lateral conjunctival approach of transecting the ciliary nerves, resulting in a complete loss of sensory innervation. 49 Our pilot studies demonstrated that sensory nerve denervation leads to a significant increase in the expression of vascular adhesion molecules, and increased adhesion of cDC rolling and sticking in vivo-required for active migration into the cornea -translating to an influx of bone marrow-derived cells, including cDCs, into the peripheral and central cornea as early as 24 hours after surgery. 50 This was followed by an increase in the secretion of proinflammatory cytokines, including IL-1b, IL-6, and IL-17, as well as increased hemangiogenesis and lymphangiogenesis. 50 Furthermore, analyses of cDC kinetics after complete or partial central ciliary nerve axotomy, but not peripheral nerve axotomy, and corneal denervation in isogeneic and allogeneic corneal transplantation, revealed a significant increase in cDC motility in the cornea and ipsilateral dLNs. 51 Moreover, axotomy before corneal transplantation resulted in the rejection of all grafts and a positive donor specific delayedtype hypersensitivity response in mice at 2 weeks compared with a lack of response in mice after allogeneic corneal transplantation without prior axotomy.
Recently, Paunicka et al 52 demonstrated that a circular corneal incision in contralateral eyes leads to a marked upregulation of neuropeptides such as substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide, suggesting the sympathetic regulation of neuropeptides in the cornea. Clinically, NTK, 53 which is often refractory to therapy, may result in deceased visual acuity and corneal scarring/melting, necessitating corneal transplantation. However, it is well established that corneal transplants in NTK recipients have a very high rate of graft rejection, although corneal allografts typically have an exceptionally high acceptance rate that often exceeds 85%. 54 Although the low success rate in patients with NTK has been associated with poor ocular surface, our data suggest that deregulation or loss of corneal nerves may result in the loss of immune privilege and increased inflammation. Taken together, our findings indicate that the peripheral nervous system plays a critical role in maintaining corneal immune privilege, where the loss of corneal innervation results in the immediate breakdown of immune privilege. Thus, neuroregenerative treatments might provide a new avenue for the treatment of immune and inflammatory diseases, as reinnervation of the nervous system would then result in the subsequent regulation of the immune response, such as in corneal transplantation and DED. In summary, our translational approach to ocular immunology has resulted in a rapid and novel characterization/dissection of the corneal neuroimmune crosstalk.
